{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:46:50Z","timestamp":1788536810003,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"New York State Office of Addiction Services and Supports"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Drug overdose is a leading cause of death and opioid-related deaths increased by more than 300% from 2010 to 2020 in New York State. Experts holding a range of senior leadership positions from across New York State were asked to identify the greatest challenges in substance misuse prevention, harm reduction, and treatment continuum of care. Expert input was used to shape funding priorities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Individual semi-structured interviews of sixteen experts were conducted in April and May 2023. Experts included academics, medical directors, leaders of substance misuse service agencies, administrators of a state agency, a county mental health commissioner, the president of a pharmacy chain, and a senior vice president of an addiction-related national non-profit. Zoom interviews were conducted individually by an experienced qualitative interviewer and were recorded, transcribed, and coded for content. An initial report, with the results of the interviews organized by thematic content, was reviewed by the research team and emailed to the expert interviewees for feedback.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The research team identified five major themes: 1. Siloed and fragmented care delivery systems; 2. Need for a skilled workforce; 3. Attitudes towards addiction (stigma); 4. Limitations in treatment access; and 5. Social and drug related environmental factors. Most experts identified challenges in each major theme; over three-quarters identified issues related to siloed and fragmented systems and the need for a skilled workforce. Each expert mentioned more than one theme, three experts mentioned all five themes and six experts mentioned four themes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Research, educational, and programmatic agendas should focus on identified topics as a means of improving the lives of patients at risk for or suffering from substance use-related disorders. The results of this project informed funding of pilot interventions designed to address the identified care challenges.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-024-01045-3","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T03:08:44Z","timestamp":1721012924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessing experts\u2019 perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State"],"prefix":"10.1186","volume":"21","author":[{"given":"Daniel J.","family":"Kruger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lorraine","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Ditre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbian","family":"Fletcher-Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Marraffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Clemency","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"1045_CR1","unstructured":"New York State Department of Health. Priority Area: Mental Health\/Substance Abuse-Substance Abuse. https:\/\/www.health.ny.gov\/prevention\/prevention_agenda\/mental_health_and_substance_abuseuse\/substance_abuse.htm#:~:text=The%20Burden%20of%20Substance%20Abuse&text=Statewide%2C%20over%201.9%20million%20New,a%20figure%20totaling%20over%20750%2C000. Accessed 30 March 2023."},{"key":"1045_CR2","unstructured":"New York State Department of Health. Behavioral Risk Factor Surveillance Survey Summary Report. 2020. https:\/\/www.health.ny.gov\/statistics\/brfss\/"},{"key":"1045_CR3","unstructured":"New York State Department of Health. New York State Opioid Data State Dashboard. https:\/\/apps.health.ny.gov\/public\/tabvis\/PHIG_Public\/opioid\/reports\/#state. Accessed 13 June 2024."},{"key":"1045_CR4","unstructured":"New York State Department of Health. New York State Behavioral Risk Factor Surveillance System Brief: Binge and Heavy Drinking. 2024. https:\/\/www.health.ny.gov\/statistics\/brfss\/reports\/docs\/2024-08_brfss_binge_heavy_drinking.pdf. Accessed 13 June 2024."},{"issue":"1","key":"1045_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13011-020-00326-x","volume":"15","author":"L Caton","year":"2020","unstructured":"Caton L, Yuan M, Louie D, et al. The prospects for sustaining evidence-based responses to the US opioid epidemic: state leadership perspectives. Subst Use Treat PR. 2020;15(1):84. https:\/\/doi.org\/10.1186\/s13011-020-00326-x.","journal-title":"Subst Use Treat PR"},{"issue":"1","key":"1045_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13012-021-01182-4","volume":"17","author":"EL Crable","year":"2022","unstructured":"Crable EL, Benintendi A, Jones DK, Walley AY, Hicks JM, Drainoni M-L. Translating Medicaid policy into practice: policy implementation strategies from three US states\u2019 experiences enhancing substance use disorder treatment. Implement Sci. 2022;17(1):3. https:\/\/doi.org\/10.1186\/s13012-021-01182-4.","journal-title":"Implement Sci"},{"issue":"11","key":"1045_CR7","first-page":"1085","volume":"79","author":"J Sayers","year":"2001","unstructured":"Sayers J. The world health report 2001\u2014mental health: new understanding, new hope. Bull World Health Organ. 2001;79(11):1085.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1045_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-024-00971-6","volume":"21","author":"M Rehman","year":"2024","unstructured":"Rehman M, Chapman L, Liu L, Calvert S, Sukhera J. Structural stigma within inpatient care for people who inject drugs: implications for harm reduction. Harm Reduct J. 2024;21(1):53. https:\/\/doi.org\/10.1186\/s12954-024-00971-6.","journal-title":"Harm Reduct J"},{"issue":"1\u20132","key":"1045_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.02.018.","journal-title":"Drug Alcohol Depend"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/SAR.S304566","volume":"13","author":"A Cheetham","year":"2022","unstructured":"Cheetham A, Picco L, Barnett A, Lubman DI, Nielsen S. The impact of stigma on people with opioid use disorder, opioid treatment, and policy. Subst Abuse Rehabil. 2022;13:1\u201312. https:\/\/doi.org\/10.2147\/SAR.S304566.","journal-title":"Subst Abuse Rehabil"},{"issue":"2","key":"1045_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/16066350701850295","volume":"16","author":"JB Luoma","year":"2008","unstructured":"Luoma JB, Kohlenberg BS, Hayes SC, Bunting K, Rye AK. Reducing self-stigma in substance abuse through acceptance and commitment therapy: Model, manual development, and pilot outcomes. Addict Res Theory. 2008;16(2):149\u201365. https:\/\/doi.org\/10.1080\/16066350701850295.","journal-title":"Addict Res Theory"},{"issue":"2","key":"1045_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jpm.12794","volume":"29","author":"CW Chang","year":"2022","unstructured":"Chang CW, Chang KC, Griffiths MD, Chang CC, Lin CY, Pakpour AH. The mediating role of perceived social support in the relationship between perceived stigma and depression among individuals diagnosed with substance use disorders. J Psychiatr Ment Health Nurs. 2022;29(2):307\u201316. https:\/\/doi.org\/10.1111\/jpm.12794.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"12","key":"1045_CR13","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1007\/s10461-018-2201-7","volume":"22","author":"VA Earnshaw","year":"2018","unstructured":"Earnshaw VA, Kidman RC, Violari A. Stigma, depression, and substance use problems among perinatally HIV-infected youth in South Africa. AIDS Behav. 2018;22(12):3892\u20136. https:\/\/doi.org\/10.1007\/s10461-018-2201-7.","journal-title":"AIDS Behav"},{"issue":"2","key":"1045_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/14659891.2021.1916846","volume":"27","author":"N Bozda\u011f","year":"2022","unstructured":"Bozda\u011f N, \u00c7uhadar D. Internalized stigma, self-efficacy and treatment motivation in patients with substance use disorders. J Subs Use. 2022;27(2):174\u201380. https:\/\/doi.org\/10.1080\/14659891.2021.1916846.","journal-title":"J Subs Use"},{"issue":"2","key":"1045_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jpm.12794","volume":"29","author":"CW Chang","year":"2022","unstructured":"Chang CW, Chang KC, Griffiths MD, Chang CC, Lin CY, Pakpour AH. The mediating role of perceived social support in the relationship between perceived stigma and depression among individuals diagnosed with substance use disorders. J Psychiatr Nurs. 2022;29(2):307\u201316. https:\/\/doi.org\/10.1111\/jpm.12794.","journal-title":"J Psychiatr Nurs"},{"key":"1045_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108486","volume":"131","author":"J Bielenberg","year":"2021","unstructured":"Bielenberg J, Swisher G, Lembke A, Haug NA. A systematic review of stigma interventions for providers who treat patients with substance use disorders. J Subst Abuse Treat. 2021;131:108486. https:\/\/doi.org\/10.1016\/j.jsat.2021.108486.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"1045_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1037\/tra0000511","volume":"12","author":"WK Lee","year":"2020","unstructured":"Lee WK, Hayashi K, DeBeck K, et al. Association between posttraumatic stress disorder and nonfatal drug overdose. Psychol Trauma. 2020;12(4):373\u201380. https:\/\/doi.org\/10.1037\/tra0000511.","journal-title":"Psychol Trauma"},{"issue":"2","key":"1045_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/lrh2.10186","volume":"3","author":"WB Rouse","year":"2019","unstructured":"Rouse WB, Johns MME, Pepe KM. Service supply chains for population health: overcoming fragmentation of service delivery ecosystems. Learn Health Syst. 2019;3(2):e10186. https:\/\/doi.org\/10.1002\/lrh2.10186.","journal-title":"Learn Health Syst"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","volume":"61","author":"MA Priester","year":"2016","unstructured":"Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 2016;61:47\u201359. https:\/\/doi.org\/10.1016\/j.jsat.2015.09.006.","journal-title":"J Subst Abuse Treat"},{"key":"1045_CR20","unstructured":"Innovations in Addictions Treatment: Addiction treatment providers working with integrated primary care services. Substance abuse and mental health services administration. 2013."},{"key":"1045_CR21","unstructured":"United States Government Accountability Office. Behavioral health: available workforce information and federal actions to help recruit and retain providers. Congressional publications. 2022."},{"key":"1045_CR22","unstructured":"United States Health Resources and Services Administration. Behavioral health workforce projections, 2017\u20132030. Accessed 31 August 2023. https:\/\/bhw.hrsa.gov\/sites\/default\/files\/bureau-health-workforce\/data-research\/bh-workforce-projections-fact-sheet.pdf"},{"issue":"2","key":"1045_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1353\/cpr.2021.0018","volume":"15","author":"SL Hutchison","year":"2021","unstructured":"Hutchison SL, Herschell AD, Clauss K, Hovorka K, Wasilchak DS, Hurford MO. Payer-provider partnership to identify successful retention strategies for the behavioral health workforce. Prog Community Health Partnersh. 2021;15(2):151\u201360. https:\/\/doi.org\/10.1353\/cpr.2021.0018.","journal-title":"Prog Community Health Partnersh"},{"issue":"11","key":"1045_CR24","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1377\/hlthaff.2013.0541","volume":"32","author":"MA Hoge","year":"2013","unstructured":"Hoge MA, Stuart GW, Morris J, Flaherty MT, Paris M, Goplerud E. Analysis & commentary mental health and addiction workforce development: federal leadership is needed to address the growing crisis. Health Aff. 2013;32(11):2005\u201312. https:\/\/doi.org\/10.1377\/hlthaff.2013.0541.","journal-title":"Health Aff"},{"issue":"13","key":"1045_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/adaw.32314","volume":"31","author":"A Knopf","year":"2019","unstructured":"Knopf A. Bipartisan policy center says to keep up the funding, but make it more flexible and sustainable. Alcoholism Drug Abuse Weekly. 2019;31(13):5\u20136. https:\/\/doi.org\/10.1002\/adaw.32314.","journal-title":"Alcoholism Drug Abuse Weekly"},{"issue":"1","key":"1045_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/02791072.2013.763558","volume":"45","author":"CB Oser","year":"2013","unstructured":"Oser CB, Biebel EP, Pullen E, Harp KLH. Causes, consequences, and prevention of burnout among substance abuse treatment counselors: a rural versus urban comparison. J Psychoactive Drugs. 2013;45(1):17\u201327. https:\/\/doi.org\/10.1080\/02791072.2013.763558.","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"1045_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s10488-015-0673-6","volume":"43","author":"RS Beidas","year":"2016","unstructured":"Beidas RS, Marcus S, Wolk CB, et al. A prospective examination of clinician and supervisor turnover within the context of implementation of evidence-based practices in a publicly-funded mental health system. Adm Policy Ment Health. 2016;43(5):640\u20139. https:\/\/doi.org\/10.1007\/s10488-015-0673-6.","journal-title":"Adm Policy Ment Health"},{"issue":"2","key":"1045_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/08897077.2018.1561596","volume":"40","author":"L Gorfinkel","year":"2019","unstructured":"Gorfinkel L, Klimas J, Reel B, et al. In-hospital training in addiction medicine: a mixed-methods study of health care provider benefits and differences. Subs abus. 2019;40(2):207\u201313. https:\/\/doi.org\/10.1080\/08897077.2018.1561596.","journal-title":"Subs abus"},{"issue":"6","key":"1045_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024659","volume":"9","author":"T Kourgiantakis","year":"2019","unstructured":"Kourgiantakis T, Sewell K, McNeil S, et al. Social work education and training in mental health, addictions and suicide: a scoping review protocol. BMJ Open. 2019;9(6):e024659. https:\/\/doi.org\/10.1136\/bmjopen-2018-024659.","journal-title":"BMJ Open"},{"issue":"1","key":"1045_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/08897077.2014.933153","volume":"36","author":"JL Russett","year":"2015","unstructured":"Russett JL, Williams A. An exploration of substance abuse course offerings for students in counseling and social work programs. Subst Abus. 2015;36(1):51\u20138. https:\/\/doi.org\/10.1080\/08897077.2014.933153.","journal-title":"Subst Abus"},{"issue":"3","key":"1045_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ceas.12070","volume":"56","author":"G Lawson","year":"2017","unstructured":"Lawson G, Trepal HC, Lee RW, Kress V. Advocating for educational standards in counselor licensure laws. Couns Educ Superv. 2017;56(3):162\u201376. https:\/\/doi.org\/10.1002\/ceas.12070.","journal-title":"Couns Educ Superv"},{"issue":"1","key":"1045_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.15241\/so.8.1.88","volume":"8","author":"S Olson","year":"2018","unstructured":"Olson S, Brown-Rice K, Gerodias A. Professional counselor licensure portability: an examination of state license applications. Prof Couns (Greensb, NC). 2018;8(1):88\u2013103. https:\/\/doi.org\/10.15241\/so.8.1.88.","journal-title":"Prof Couns (Greensb, NC)"},{"issue":"1","key":"1045_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13011-022-00509-8","volume":"18","author":"REE Barenie","year":"2023","unstructured":"Barenie REE, Cernasev A, Heidel RE, Stewart S, Hohmeier K. Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study. Subst Abuse Treat PR. 2023;18(1):2\u201310. https:\/\/doi.org\/10.1186\/s13011-022-00509-8.","journal-title":"Subst Abuse Treat PR"},{"issue":"6 Suppl 3","key":"1045_CR34","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","volume":"54","author":"RL Haffajee","year":"2018","unstructured":"Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 2018;54(6 Suppl 3):S230-s242. https:\/\/doi.org\/10.1016\/j.amepre.2017.12.022.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1045_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13011-020-00284-4","volume":"15","author":"A Acevedo","year":"2020","unstructured":"Acevedo A, Harvey N, Kamanu M, Tendulkar S, Fleary S. Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers. Subst Abuse Treat Prev Policy. 2020;15(1):42. https:\/\/doi.org\/10.1186\/s13011-020-00284-4.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1045_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jrh.12129","volume":"32","author":"T Browne","year":"2016","unstructured":"Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health Winter. 2016;32(1):92\u2013101. https:\/\/doi.org\/10.1111\/jrh.12129.","journal-title":"J Rural Health Winter"},{"key":"1045_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100029","volume":"2","author":"A Cernasev","year":"2021","unstructured":"Cernasev A, Hohmeier KC, Frederick K, Jasmin H, Gatwood J. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. Explor Res Clin Soc Pharm. 2021;2:100029. https:\/\/doi.org\/10.1016\/j.rcsop.2021.100029.","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"1045_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jrh.12488","volume":"38","author":"MM Ali","year":"2022","unstructured":"Ali MM, Nye E, West K. Substance use disorder treatment, perceived need for treatment, and barriers to treatment among parenting women with substance use disorder in us rural counties. J Rural Health. 2022;38(1):70\u20136. https:\/\/doi.org\/10.1111\/jrh.12488.","journal-title":"J Rural Health"},{"key":"1045_CR39","doi-asserted-by":"publisher","first-page":"108341","DOI":"10.1016\/j.jsat.2021.108341","volume":"126","author":"ER Barnett","year":"2021","unstructured":"Barnett ER, Knight E, Herman RJ, Amarakaran K, Jankowski MK. Difficult binds: a systematic review of facilitators and barriers to treatment among mothers with substance use disorders. J Subst Abus Treat. 2021;126:108341. https:\/\/doi.org\/10.1016\/j.jsat.2021.108341.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"1045_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12954-024-00964-5","volume":"21","author":"J Dickson-Gomez","year":"2024","unstructured":"Dickson-Gomez J, Krechel S, Ohlrich J, et al. They make it too hard and too many hoops to jump: system and organizational barriers to drug treatment during epidemic rates of opioid overdose. Harm Reduct J. 2024;21(1):52. https:\/\/doi.org\/10.1186\/s12954-024-00964-5.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01045-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T03:13:13Z","timestamp":1721013193000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01045-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article. JJL and BMC are also funded by Overdose Data to Action in NYS (U17CE924974) from the Centers for Disease Control and Prevention and the New York State Department of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The project (STUDY00008069) was reviewed by the University at Buffalo Institutional Review Board and was determined to not be human subjects research, as the content discussed was regarding the health system and did not include any information about the individuals interviewed. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have contributed substantially to the project and have approved the final version of this manuscript to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"134"}}